Northstar Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Buy
2,331
+1
+0% +$117 0.09% 103
2026
Q1
$280K Buy
2,330
+2
+0.1% +$231 0.1% 100
2025
Q4
$245K Sell
2,328
-74
-3% -$6.95K 0.09% 101
2025
Q3
$202K Buy
+2,402
New +$198K 0.08% 110
2025
Q2
Sell
-2,397
Closed -$215K 108
2025
Q1
$215K Sell
2,397
-196
-8% -$18.3K 0.14% 93
2024
Q4
$258K Sell
2,593
-94
-3% -$9.69K 0.13% 89
2024
Q3
$305K Sell
2,687
-25,671
-91% -$3.05M 0.16% 83
2024
Q2
$3.53M Sell
28,358
-1,234
-4% -$159K 2.03% 14
2024
Q1
$3.85M Buy
29,592
+26,953
+1,021% +$3.32M 2.33% 12
2023
Q4
$288K Buy
2,639
+3
+0.1% +$311 0.17% 73
2023
Q3
$271K Buy
2,636
+2
+0.1% +$216 0.2% 74
2023
Q2
$304K Buy
2,634
+60
+2% +$6.81K 0.2% 71
2023
Q1
$274K Sell
2,574
-47
-2% -$5.07K 0.2% 72
2022
Q4
$291K Buy
2,621
+4
+0.2% +$409 0.23% 75
2022
Q3
$225K Buy
+2,617
New +$234K 0.2% 76

Other funds holding MRK

Northstar Advisory Group's MRK Position: Q2 2026 in Review

Northstar Advisory Group increased its Merck (MRK) stake by 0.04% in Q2 2026, buying an estimated $117 and bringing the position to 2,331 shares worth $300K. The position accounts for 0.09% of the portfolio, ranked #103.

Northstar Advisory Group first reported a position in MRK in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.85M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Northstar Advisory Group held 2,331 shares of Merck worth $300K as of Q2 2026.
  • Northstar Advisory Group bought 1 Merck share in Q2 2026, an estimated $117.
  • Merck made up 0.09% of Northstar Advisory Group's portfolio in Q2 2026, its #103 holding.
  • Northstar Advisory Group first reported a position in Merck in Q3 2022 and has held it in 15 quarters since.
  • Northstar Advisory Group's Merck position peaked at $3.85M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Northstar Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.